Teleflex Incorporated $TFX Shares Sold by Invesco Ltd.

Key Points

• Invesco Ltd. has reduced its holdings in Teleflex by 87.5%, selling 934,736 shares, leaving them with 133,857 shares valued at approximately $18.5 million.
• Teleflex reported a quarterly earnings per share (EPS) of $3.73, exceeding analyst expectations of $3.36, with revenue of $780.9 million for the quarter.
• The company announced a quarterly dividend of $0.34 per share, representing an annual yield of 1.1%, with the ex-dividend date set for August 15th.

Invesco Ltd. decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 87.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 133,857 shares of the medical technology company's stock after selling 934,736 shares during the period. Invesco Ltd. owned about 0.30% of Teleflex worth $18,498,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Diamond Hill Capital Management Inc. increased its stake in Teleflex by 122.8% during the first quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock valued at $80,784,000 after purchasing an additional 322,222 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Teleflex by 26.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 512,144 shares of the medical technology company's stock valued at $91,150,000 after purchasing an additional 108,189 shares during the last quarter. TD Asset Management Inc increased its stake in Teleflex by 0.7% during the first quarter. TD Asset Management Inc now owns 490,000 shares of the medical technology company's stock valued at $67,713,000 after purchasing an additional 3,310 shares during the last quarter. Northern Trust Corp increased its stake in Teleflex by 15.2% during the fourth quarter. Northern Trust Corp now owns 462,846 shares of the medical technology company's stock valued at $82,377,000 after purchasing an additional 61,219 shares during the last quarter. Finally, Deutsche Bank AG grew its position in shares of Teleflex by 62.5% during the fourth quarter. Deutsche Bank AG now owns 407,129 shares of the medical technology company's stock worth $72,461,000 after acquiring an additional 156,524 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

Insider Buying and Selling

In other Teleflex news, Director Stuart A. Randle purchased 1,000 shares of the business's stock in a transaction on Tuesday, August 5th. The stock was bought at an average cost of $115.86 per share, with a total value of $115,860.00. Following the acquisition, the director owned 7,547 shares of the company's stock, valued at $874,395.42. The trade was a 15.27% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Gretchen R. Haggerty purchased 500 shares of the business's stock in a transaction on Wednesday, August 6th. The stock was acquired at an average cost of $114.75 per share, with a total value of $57,375.00. Following the completion of the acquisition, the director directly owned 6,305 shares in the company, valued at $723,498.75. The trade was a 8.61% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 5,500 shares of company stock worth $633,590 in the last ninety days. Insiders own 1.40% of the company's stock.

Teleflex Price Performance

TFX stock traded up $2.18 during trading on Wednesday, hitting $129.42. The company had a trading volume of 640,792 shares, compared to its average volume of 580,884. The firm has a market capitalization of $5.72 billion, a price-to-earnings ratio of 30.45, a P/E/G ratio of 1.77 and a beta of 1.08. The business has a 50 day moving average of $118.71 and a 200 day moving average of $130.01. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping the consensus estimate of $3.36 by $0.37. The business had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company's quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.42 earnings per share. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's dividend payout ratio is presently 32.00%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on TFX. Morgan Stanley lowered their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. Mizuho upped their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. Wells Fargo & Company lowered their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Finally, Royal Bank Of Canada upped their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research report on Friday, August 1st. One analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Teleflex has a consensus rating of "Hold" and a consensus price target of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.